MRKR - Marker Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts5555
Avg. Estimate-0.13-0.12-0.49-0.53
Low Estimate-0.15-0.14-0.52-0.66
High Estimate-0.1-0.11-0.46-0.47
Year Ago EPS-1.02-0.12-1.67-0.49
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts5555
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/A206kN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.2-0.17-0.13-0.13
EPS Actual-1.02-0.12-0.12-0.12
Difference-0.820.050.010.01
Surprise %-410.00%29.40%7.70%7.70%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.13-0.12-0.49-0.53
7 Days Ago-0.14-0.13-0.52-0.54
30 Days Ago-0.14-0.13-0.52-0.54
60 Days Ago-0.14-0.13-0.52-0.54
90 Days Ago-0.14-0.13-0.52-0.54
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 Days1112
Up Last 30 Days4142
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesMRKRIndustrySectorS&P 500
Current Qtr.87.30%N/AN/A0.02
Next Qtr.N/AN/AN/A0.06
Current Year70.70%N/AN/A-0.03
Next Year-8.20%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A